Blue Diamond Ventures Inc (BLDV)

[Numbmonk]

?
Cann10

New agreement between Cann10 and Epigenetics to improve cannabis plant and optimize its growth

Telniri | 22.12.19, 11:36

Cannabis Cann10 has signed an agreement with EPI GENETICS to enable, for the first time in the world, to improve cannabis plant using innovative epigenetics-based technology; Tens of thousands of dollars will be invested in the study

The goal of the collaboration is to improve the occurrence of desirable plant properties and increase its efficiency and quality of growth

Cann10, which manufactures medical cannabis products and technologies, signed a cooperation agreement with EPI GENETICS, which developed an innovative technology based on epigenetics to improve the occurrence of desirable plants. The innovative technology will allow the selected genes to be planted to the forefront, thus optimizing the effectiveness of cannabis growing and treatment. Among the founders of EPI GENETICS is the researcher, Dr. Avner Schenfeld, CEO of Cann10 is Uri Alfrovitz.

As part of the agreement, Cann10 and EPI GENETICS will invest tens of thousands of dollars together to advance the research of the cannabis plant in the new technology. In the next few weeks, the first research into the new technology will begin within the cannabis farm of the public company "Medical Group Discourse", with preliminary results of the study expected to be revealed within 6 months. The innovative technology is expected to be sold as a franchise to grow cannabis in Israel and around the world, thus improving the efficiency and productivity of farms in the global cannabis industry.

The collaboration between companies is expected to optimize cannabis growth by promoting features that improve its quality - increasing the concentration of active ingredients in the plant, thereby maximizing the active ingredient in the growth, as well as increasing the amount of biomass in the plant.

Under the agreement signed, a joint company will be established under the name Cann10 EpiGen. Cann10, inter alia through a dialog company, will provide the appropriate infrastructure for conducting research, validating and testing the technology, as well as accompanying the entire business development and marketing process of the company. EPI GENETICS will harness the proven technology and experience in other crops to promote the development of cannabis epigenetics.

Plant enhancement is a development method to strengthen the desired properties of the plant. Epigenetics technology is a state-of-the-art third-generation enhancement, focusing on revealing hidden parts of the cannabis plant's DNA and enabling expression of selected genes in the green plant. The method is currently applied to various agricultural crops around the world. For example, in experiments carried out on tomatoes and corn, technology has been able to increase 100 times the level of photosynthesis in plants and thus greatly increase the crop.

Cann10 is a medical cannabis products and technology company in the field, which, among its activities, markets the Cannareet Cannareet product line and operates a CannXL innovation center in the cannabis field.

Uri Alprovich, CEO of Cann10: "The collaboration with EPI GENETICS is the result of a constant search for the next exceptional development in cannabis. We believe that innovative development is expected to change the rules of the global cannabis growing industry. The new collaboration is a significant milestone in realizing the company's strategy for expanding its operations in Israel and abroad, and increasing its production capacity through the use of innovative growing technologies, and advancing cannabis research and development.

https://www.talniri.co.il/marketnews/article.asp?mp=null&cat=4&id=97279